APA Citatie

Levitan, B., Yuan, Z., Turpie, A. G., Friedman, R. J., Homering, M., Berlin, J. A., . . . DiBattiste, P. M. (2014). Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty. Dove Medical Press.

Chicago Style citaat

Levitan, Bennett, Zhong Yuan, Alexander GG Turpie, Richard J. Friedman, Martin Homering, Jesse A. Berlin, Scott D. Berkowitz, Rachel B. Weinstein, en Peter M. DiBattiste. Benefit–risk Assessment of Rivaroxaban Versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Arthroplasty. Dove Medical Press, 2014.

MLA citatie

Levitan, Bennett, et al. Benefit–risk Assessment of Rivaroxaban Versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Arthroplasty. Dove Medical Press, 2014.